Differential expression of survivin and its splice variants, survivin-ΔEx3 and survivin-2B, in bladder cancer

Ambrosini, 1997, A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma, Nat Med, 3, 917, 10.1038/nm0897-917 Velculescu, 1999, Analysis of human transcriptomes, Nat Genet, 23, 387, 10.1038/70487 Mahotka, 1999, Survivin-deltaEx3 and survivin-2B: two novel splice variants of the apoptosis inhibitor survivin with different antiapoptotic properties, Cancer Res, 59, 6097 Badran, 2004, Identification of a novel splice variant of the human anti-apoptosis gene survivin, Biochem Biophys Res Commun, 314, 902, 10.1016/j.bbrc.2003.12.178 Islam, 2000, Role of survivin, whose gene is mapped to 17q25, in human neuroblastoma and identification of a novel dominant-negative isoform, survivin-beta/2B, Med Pediatr Oncol, 35, 550, 10.1002/1096-911X(20001201)35:6<550::AID-MPO12>3.0.CO;2-Y Mostofi, 1973, Histologic typing of urinary bladders Atlasi, 2007, OCT-4, an embryonic stem cell marker, is highly expressed in bladder cancer, Int J Cancer, 120, 1598, 10.1002/ijc.22508 Hollander, 1999 Hogg, 1995 Smith, 2001, Urine detection of survivin and diagnosis of bladder cancer, JAMA, 285, 324, 10.1001/jama.285.3.324 Shariat, 2004, Urine detection of survivin is a sensitive marker for the noninvasive diagnosis of bladder cancer, J Urol, 171, 626, 10.1097/01.ju.0000107826.78479.90 Schultz, 2004, Survivin mRNA copy number in bladder washings predicts tumor recurrence in patients with superficial urothelial cell carcinomas, Clin Chem, 50, 1425, 10.1373/clinchem.2004.032003 Schultz, 2003, Survivin mRNA expression is elevated in malignant urothelial cell carcinomas and predicts time to recurrence, Anticancer Res, 23, 3327 Ryan, 2005, Expression of survivin and its splice variants survivin-2B and survivin-deltaEx3 in breast cancer, Br J Cancer, 92, 120, 10.1038/sj.bjc.6602314 Krieg, 2002, Expression of different survivin variants in gastric carcinomas: first clues to a role of survivin-2B in tumour progression, Br J Cancer, 86, 737, 10.1038/sj.bjc.6600153 Meng, 2004, Prognostic significance and different properties of survivin splicing variants in gastric cancer, Cancer Lett, 216, 147, 10.1016/j.canlet.2003.12.020 Weikert, 2005, Quantitative analysis of survivin mRNA expression in urine and tumor tissue of bladder cancer patients and its potential relevance for disease detection and prognosis, Int J Cancer, 116, 100, 10.1002/ijc.21000 Lehner, 2002, Immunohistochemical localization of the IAP protein survivin in bladder mucosa and transitional cell carcinoma, Appl Immunohistochem Mol Morphol, 10, 134, 10.1097/00022744-200206000-00007 Altieri, 2003, Validating survivin as a cancer therapeutic target, Nat Rev Cancer, 3, 46, 10.1038/nrc968 Adida, 1998, Developmentally regulated expression of the novel cancer anti-apoptosis gene survivin in human and mouse differentiation, Am J Pathol, 152, 43 Tran, 1999, Marked induction of the IAP family antiapoptotic proteins survivin and XIAP by VEGF in vascular endothelial cells, Biochem Biophys Res Commun, 264, 781, 10.1006/bbrc.1999.1589 Monzo, 1999, A novel anti-apoptosis gene: re-expression of survivin messenger RNA as a prognosis marker in non-small-cell lung cancers, J Clin Oncol, 17, 2100, 10.1200/JCO.1999.17.7.2100 Zhang, 2001, Evidence that APC regulates survivin expression: a possible mechanism contributing to the stem cell origin of colon cancer, Cancer Res, 62, 8664 Caldas, 2005, Survivin splice variants regulate the balance between proliferation and cell death, Oncogene, 12, 1994, 10.1038/sj.onc.1208350